FDG PET/CT 显示前列腺癌胰腺转移。
FDG PET/CT demonstration of pancreatic metastasis from prostate cancer.
机构信息
Department of Radiology, PET Imaging Science Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
出版信息
Clin Nucl Med. 2011 Oct;36(10):961-2. doi: 10.1097/RLU.0b013e3182291d1a.
Abstract
We report the hybrid FDG PET/CT appearance of a biopsy-proven pancreatic metastasis from prostate cancer in a man with castrate-resistant metastatic disease. The common sites of metastases from prostate cancer are bone and locoregional lymph nodes. Pancreas is an atypical location of metastasis from prostate cancer. PET/CT in this case helped with the targeted pathologic confirmation to differentiate primary pancreatic tumor from an unusual metastasis from prostate cancer which in turn impacted the clinical management.
摘要
我们报告了一例经活检证实的前列腺癌胰腺转移的混合 FDG PET/CT 表现，该患者患有去势抵抗性转移性疾病。前列腺癌转移的常见部位是骨骼和局部淋巴结。胰腺是前列腺癌转移的非典型部位。本例中的 PET/CT 有助于有针对性的病理证实，以区分原发性胰腺肿瘤和来自前列腺癌的不常见转移，这反过来又影响了临床管理。
相似文献
1
FDG PET/CT demonstration of pancreatic metastasis from prostate cancer.FDG PET/CT 显示前列腺癌胰腺转移。
Clin Nucl Med. 2011 Oct;36(10):961-2. doi: 10.1097/RLU.0b013e3182291d1a.
2
(18)F-FDG-PET/CT findings in pancreatic metastasis.胰腺转移瘤的（18）F-FDG-PET/CT表现。
Radiol Med. 2015 Oct;120(10):887-98. doi: 10.1007/s11547-014-0473-1. Epub 2015 Mar 22.
3
Comment on: "Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT".对《通过动态18F-FDG PET/CT评估胰腺癌的肿瘤侵袭性和患者预后》的评论
J Nucl Med. 2014 Feb;55(2):350-1. doi: 10.2967/jnumed.113.130138. Epub 2013 Dec 9.
4
Reply: Comment on: "Tumor aggressiveness and patient outcome in cancer of the pancreas assessed by dynamic 18F-FDG PET/CT".回复：对“通过动态18F-FDG PET/CT评估胰腺癌的肿瘤侵袭性和患者预后”的评论
J Nucl Med. 2014 Feb;55(2):351-2. doi: 10.2967/jnumed.113.132845. Epub 2013 Dec 9.
5
Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在胰腺肿块特征描述中的作用：热带地区的经验。
J Gastroenterol Hepatol. 2013 Feb;28(2):255-61. doi: 10.1111/jgh.12068.
6
Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.对比增强 FDG-PET/CT 在胰腺癌临床管理中的应用：对诊断、分期、治疗反应评估和复发检测的影响。
Pancreas. 2013 Jan;42(1):11-9. doi: 10.1097/MPA.0b013e3182550d77.
7
Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumours.3'-去氧-3'-[¹⁸F]氟代胸苷正电子发射断层扫描（FLT PET）与 FDG PET/CT 用于胰腺肿瘤的检测和特征分析的比较。
Eur J Nucl Med Mol Imaging. 2012 May;39(5):846-51. doi: 10.1007/s00259-012-2061-8. Epub 2012 Jan 26.
8
Asymptomatic Solitary Metastasis to the Testis From Prostate Carcinoma Detected by FDG PET/CT.前列腺癌患者经 FDG PET/CT 检测出无症状孤立性睾丸转移。
Clin Nucl Med. 2016 Jan;41(1):86-7. doi: 10.1097/RLU.0000000000001004.
9
Usefulness of 18F-FDG PET/CT in an unusual case of solid-pseudopapillary pancreatic tumor in childhood with aggressive behavior.18F-FDG PET/CT 在儿童胰腺实性假乳头状瘤伴侵袭性行为这一不常见病例中的应用。
Clin Nucl Med. 2013 Jan;38(1):e35-7. doi: 10.1097/RLU.0b013e31824c5e92.
10
The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer.正电子发射断层扫描/计算机断层扫描在评估胰腺癌患者转移性疾病中的价值。
Pancreas. 2012 Aug;41(6):897-903. doi: 10.1097/MPA.0b013e318252f4f5.
引用本文的文献
1
Atypical Metastases from Prostate Cancer: Alpha-Methylacyl-Coenzyme A Racemase (AMACR) as a Potential Molecular Target in Prostate-Specific Membrane Antigen-Negative Prostate Adenocarcinoma.前列腺癌的非典型转移：α-甲基酰基辅酶A消旋酶（AMACR）作为前列腺特异性膜抗原阴性前列腺腺癌的潜在分子靶点。
Biomolecules. 2024 Dec 26;15(1):17. doi: 10.3390/biom15010017.
2
Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer.转移性非肝胆管癌所致恶性胆道梗阻。
World J Gastroenterol. 2022 Mar 14;28(10):985-1008. doi: 10.3748/wjg.v28.i10.985.
3
(18)F-FDG-PET/CT findings in pancreatic metastasis.胰腺转移瘤的（18）F-FDG-PET/CT表现。
Radiol Med. 2015 Oct;120(10):887-98. doi: 10.1007/s11547-014-0473-1. Epub 2015 Mar 22.
4
MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.MR 分子成像在鼠原位前列腺癌模型中应用肽靶向对比剂检测前列腺癌。
Pharm Res. 2012 Apr;29(4):953-60. doi: 10.1007/s11095-011-0635-y. Epub 2011 Dec 3.
本文引用的文献
1
C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.前列腺癌骨转移男性患者的 C11-醋酸盐和 F-18 FDG PET：相对发现和治疗反应。
Clin Nucl Med. 2011 Mar;36(3):192-8. doi: 10.1097/RLU.0b013e318208f140.
2
An interesting contamination artifact appearing in I-(131) whole-body imaging after ablative therapy.一种有趣的污染伪影出现在消融治疗后的碘-131全身显像中。
Rev Esp Med Nucl. 2011 Jan-Feb;30(1):36-7. doi: 10.1016/j.remn.2010.07.003. Epub 2011 Jan 5.
3
Pancreatic metastasis from prostate cancer.前列腺癌的胰腺转移
Case Rep Med. 2010;2010:826273. doi: 10.1155/2010/826273. Epub 2010 May 23.
4
Synchronous prostate cancer incidentally detected by FDG-PET/CT in staging a patient with newly diagnosed nasopharyngeal cancer.在对一名新诊断的鼻咽癌患者进行分期时，FDG-PET/CT偶然发现的同步性前列腺癌。
Clin Nucl Med. 2009 Dec;34(12):962-3. doi: 10.1097/RLU.0b013e3181bed0ae.
5
Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET.18F-氟脱氧葡萄糖 PET 用于前列腺癌的分子成像。
Nat Rev Urol. 2009 Jun;6(6):317-23. doi: 10.1038/nrurol.2009.81. Epub 2009 May 12.
6
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.前列腺癌的转移模式：对1589例患者的尸检研究
Hum Pathol. 2000 May;31(5):578-83. doi: 10.1053/hp.2000.6698.
7
Features of unusual metastases from prostate cancer.前列腺癌罕见转移的特征。
Br J Radiol. 1999 Oct;72(862):933-41. doi: 10.1259/bjr.72.862.10673942.
8
Metastases to the pancreas.胰腺转移瘤。
Br J Radiol. 1998 Nov;71(851):1208-14. doi: 10.1259/bjr.71.851.10434919.
Zotero 插件